Longitudinal effects of Johnson & Johnson COVID-19 vaccination on metabolic biomarkers in type 2 diabetes mellitus in Ethiopia
The J&J COVID-19 vaccine exhibited metabolic safety in patients with T2DM, with transient HDL and TC reductions that later stabilized and a sustained TX decline, suggesting potential cardiovascular benefits. Further studies are needed to explore long-term immunometabolic effects on high-risk populations.
Authors
- Chala Kenenisa Edae (ORCID: https://orcid.org/0000-0002-1414-2742)
- Tibebu Girma
- Solomon Genet (ORCID: https://orcid.org/0000-0002-5433-0107)
- Maria Degef Teklemariam
- Abdisa Tufa Bedada (ORCID: https://orcid.org/0000-0003-2196-6835)
Institutions
- Addis Ababa Science and Technology University (ET)
- Addis Ababa University (ET)
- Adama Science and Technology University (ET)
Publication Details
- Journal
- World Journal of Diabetes
- Published
- 2025-06-13
- DOI
- https://doi.org/10.4239/wjd.v16.i6.105447
- Primary Topic
- COVID-19 Clinical Research Studies
- Type
- article
- Field-Weighted Citation Impact
- 0.00